Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease

被引:0
作者
Elbeltagy, M. [1 ,2 ]
Abbassy, M. [2 ,3 ]
机构
[1] Cairo Univ, Dept Neurosurg, 1 Univ St, Giza Governorate 12613, Egypt
[2] Childrens Canc Hosp Egypt, Dept Neurosurg, Sekat Hadid Al Mahger, Cairo Governorate 4260102, Egypt
[3] Alexandria Univ, Dept Neurosurg, 22 El-Gaish Rd,Al Azaritah WA Ash Shatebi, Alexandria Governorate 5424041, Egypt
关键词
Neurofibromatosis; Von Recklinghausen's disease; Tuberous sclerosis; Von Hippel-Lindau; Neurocutaneous syndromes; Phakomatosis; CENTRAL-NERVOUS-SYSTEM; OPTIC PATHWAY GLIOMA; SPINAL-CORD HEMANGIOBLASTOMAS; COMPLEX DIAGNOSTIC-CRITERIA; GIANT-CELL ASTROCYTOMAS; TUMOR-PRONE SYNDROMES; LOW-GRADE GLIOMAS; VESTIBULAR SCHWANNOMAS; RADIATION-THERAPY; NATURAL-HISTORY;
D O I
10.1007/s00381-023-06160-3
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Neurocutaneous syndromes (also known as phakomatoses) are heterogenous group of disorders that involve derivatives of the neuroectoderm. Each disease has diagnostic and pathognomonic criteria, once identified, thorough clinical examination to the patient and the family members should be done. Magnetic resonance imaging (MRI) is used to study the pathognomonic findings withing the CNS (Evans et al. in Am J Med Genet A 152A:327-332, 2010). This chapter includes the 4 most common syndromes faced by neurosurgeons and neurologists; neurofibromatosis types 1 and 2, tuberous sclerosis and Von Hippel-Lindau disease. Each syndrome has specific genetic anomaly that involves a tumor suppressor gene and the loss of inhibition of specific pathways. The result is a spectrum of cutaneous manifestations and neoplasms.
引用
收藏
页码:2791 / 2806
页数:16
相关论文
共 166 条
  • [1] Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States
    An, Kit Sing
    Williams, Aimee T.
    Roach, E. Steve
    Batchelor, Lori
    Sparagana, Steven P.
    Delgado, Mauricio R.
    Wheless, James W.
    Baumgartner, James E.
    Roa, Benjamin B.
    Wilson, Carolyn M.
    Smith-Knuppel, Teresa K.
    Cheung, Min-Yuen C.
    Whittemore, Vicky H.
    King, Terri M.
    Northrup, Hope
    [J]. GENETICS IN MEDICINE, 2007, 9 (02) : 88 - 100
  • [2] Growth rate characteristics of acoustic neuromas associated with neurofibromatosis type 2
    Abaza, MM
    Makariou, E
    Armstrong, M
    Lalwani, AK
    [J]. LARYNGOSCOPE, 1996, 106 (06) : 694 - 699
  • [3] Population-based analysis of sporadic and type 2 neurofibromatosis-associated meningiomas and schwannomas
    Antinheimo, J
    Sankila, R
    Carpén, O
    Pukkala, E
    Sainio, M
    Jääskeläinen, J
    [J]. NEUROLOGY, 2000, 54 (01) : 71 - 76
  • [4] A phase I trial of the MEK inhibitor selumetinib (AZD6244) in pediatric patients with recurrent or refractory low-grade glioma: a Pediatric Brain Tumor Consortium (PBTC) study
    Banerjee, Anuradha
    Jakacki, Regina I.
    Onar-Thomas, Arzu
    Wu, Shengjie
    Nicolaides, Theodore
    Poussaint, Tina Young
    Fangusaro, Jason
    Phillips, Joanna
    Perry, Arie
    Turner, David
    Prados, Michael
    Packer, Roger J.
    Qaddoumi, Ibrahim
    Gururangan, Sridharan
    Pollack, Ian F.
    Goldman, Stewart
    Doyle, Lawrence A.
    Stewart, Clinton F.
    Boyett, James M.
    Kun, Larry E.
    Fouladi, Maryam
    [J]. NEURO-ONCOLOGY, 2017, 19 (08) : 1135 - 1144
  • [5] The von Hippel-Lindau tumour suppressor: a multi-faceted inhibitor of tumourigenesis
    Barry, RE
    Krek, W
    [J]. TRENDS IN MOLECULAR MEDICINE, 2004, 10 (09) : 466 - 472
  • [6] Vascularity and angiogenesis as predictors of growth in optic pathway/hypothalamic gliomas
    Bartels, U
    Hawkins, C
    Ma, J
    Ho, M
    Dirks, P
    Rutka, J
    Stephens, D
    Bouffet, E
    [J]. JOURNAL OF NEUROSURGERY, 2006, 104 (05) : 314 - 320
  • [7] Germline loss-of-function mutations in SPRED1 cause a neurofibromatosis 1-like phenotype
    Brems, Hilde
    Chmara, Magdalena
    Sahbatou, Mourad
    Denayer, Ellen
    Taniguchi, Koji
    Kato, Reiko
    Somers, Riet
    Messiaen, Ludwine
    De Schepper, Sofie
    Fryns, Jean-Pierre
    Cools, Jan
    Marynen, Peter
    Thomas, Gilles
    Yoshimura, Akihiko
    Legius, Eric
    [J]. NATURE GENETICS, 2007, 39 (09) : 1120 - 1126
  • [8] Caban C, 2017, APPL CLIN GENET, V10, P1, DOI 10.2147/TACG.S90262
  • [9] Single agent vinorelbine in pediatric patients with progressive optic pathway glioma
    Cappellano, Andrea Maria
    Petrilli, Antonio Sergio
    da Silva, Nasjla Saba
    Silva, Frederico Adolfo
    Paiva, Priscila Mendes
    Cavalheiro, Sergio
    Bouffet, Eric
    [J]. JOURNAL OF NEURO-ONCOLOGY, 2015, 121 (02) : 405 - 412
  • [10] Cardellicchio S, 2014, NEUROPEDIATRICS, V45, P42, DOI 10.1055/s-0033-1360482